[1]陈泽宇,周饶饶,陈仁富,等.新型螺旋热膨胀前列腺支架与经尿道等离子前列腺电切术治疗高龄前列腺增生患者的疗效比较[J].徐州医科大学学报,2020,40(09):665-668.
 Comparison of effect between new spiral thermo-expandable prostate stent and transurethral plasma kinetic resection of prostate for elderly patients with benign prostatic hyperplasia[J].Journal of Xuzhou Medical University,2020,40(09):665-668.
点击复制

新型螺旋热膨胀前列腺支架与经尿道等离子前列腺电切术治疗高龄前列腺增生患者的疗效比较()
分享到:

《徐州医科大学学报》[ISSN:2096-3882/CN:32-1875/R]

卷:
40
期数:
2020年09期
页码:
665-668
栏目:
出版日期:
2020-09-25

文章信息/Info

Title:
Comparison of effect between new spiral thermo-expandable prostate stent and transurethral plasma kinetic resection of prostate for elderly patients with benign prostatic hyperplasia
作者:
陈泽宇周饶饶陈仁富李望薛松朱海涛王军起陈家存温儒民
文献标志码:
A
摘要:
探讨Memokath新型螺旋热膨胀前列腺支架置入术与经尿道等离子前列腺电切术治疗高龄前列腺增生(begign prostatic hyperplasia,BPH)患者的疗效比较。方法 回顾性分析2017年5月~2018年10月徐州医科大学附属医院泌尿外科治疗25例年龄大于75岁的BPH患者的临床资料和治疗效果,其中前列腺支架组10例,经尿道等离子前列腺切除术(plasma kinetic resection of prostate,PKRP)15例。比较2组患者手术时间及住院时间,术前及术后3、12月国际前列腺症状评分(IPSS)、最大尿流率(Qmax)、残余尿量(RUV)、疼痛评分(VAS)、生活质量评分(QOL),并随访术后不良反应。 结果 所有患者术后均能恢复自主排尿,支架组在手术时间[(30.3±6.9)min vs.(92.0±27.3)min]及住院时间[(3.2±1.1)d vs.( 7.3±1.9)d]均明显缩短且疼痛评分更低[(2.8±0.6)分 vs.( 4.2±1.2)分],术后3月复查Qmax在支架组改善更明显[(13.7±1.9)ml·s-1vs (15.2±1.6)ml·s-1],IPSS、RUV、QOL改善相似,无统计学差异,而术后1年随访时支架组Qmax、RUV、IPSS改善更明显(P<0.05)。两组术后未发生前列腺电切综合征、支架移位等严重并发症。结论 两种术式近期疗效相似,而Memokath支架术后1年时疗效更好,可作为不能耐受全身麻醉的高龄良性前列腺增生患者的首选治疗方法。
Abstract:
objective: To compare the efficacy of Memokath transurethal spiral thermo-expandable prostatic stent implantation and transurethral partial prostate resection for elderly patients with benign prostatic hyperplasia. Methods Retrospective analysis of the clinical data and treatment effect of 25 patients with BPH who were older than 75 years old in the Department of Urology, Xuzhou Medical University Hospital from May 2017 to October 2018, including 10 cases of prostate stent group, transurethral Plasma kinetic resection of prostate(PKRP) 15 cases. The operation time and hospitalization time of the two groups were compared. The international prostate symptom score (IPSS), maximum urinary flow rate (Qmax), residual urine volume (RUV), pain score (VAS), and quality of life (QOL) were measured before surgery and postoperative 3 and 12 months. Postoperative complications were collected. Result All patients were able to resume spontaneous urination after surgery, and the stent group was in operation time [(30.3±6.9) min vs. (92.0±27.3)min] and hospitalization time [(3.2 ± 1.1) d vs. (7.3 ± 1.9) d] were significantly shorter and the VAS was lower [(2.8 ± 0.6) vs. (4.2 ± 1.2)], The Qmax was more obvious in the stent group after 3 months of operation [(13.7±1.9) ml·s-1vs (15.2±1.6) ml·s-1], and the improvement of IPSS, RUV and QOL was similar, and there was no statistical difference. The Qmax, RUV and IPSS of the stent group were significantly improved after the follow-up of the first year (P<0.05). There were no serious complications such as prostate resection syndrome and stent displacement in the two groups
更新日期/Last Update: 2020-10-12